Shopping Cart
- Remove All
Your shopping cart is currently empty
Enflicoxib is an efficacious and safe agent for the treatment of pain and inflammation across all stages of canine osteoarthritis. Enflicoxib demonstrates a faster onset of action compared to mavacoxib, offering an improved pharmacological profile for veterinary applications.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $32 | In Stock | |
| 5 mg | Preferential | In Stock | |
| 1 mL x 10 mM (in DMSO) | $199 | In Stock |
| Description | Enflicoxib is an efficacious and safe agent for the treatment of pain and inflammation across all stages of canine osteoarthritis. Enflicoxib demonstrates a faster onset of action compared to mavacoxib, offering an improved pharmacological profile for veterinary applications. |
| In vivo | Pharmacokinetic studies of Enflicoxib were conducted following single oral and intravenous administration in rats and dogs. In both animal species, E-6087 was characterized by a long elimination half-life (20-35 hours), low plasma clearance (0.10-0.22 l h(-1) kg(-1)), and a relatively large volume of distribution (2-6 l kg(-1)). Oral bioavailability was lower in dogs compared to rats, while absorption occurred more rapidly in rats. [2] |
| Synonyms | E6087, E 6087 |
| Molecular Weight | 405.34 |
| Formula | C16H12F5N3O2S |
| Cas No. | 251442-94-1 |
| Smiles | O=S(=O)(N)C1=CC=C(C=C1)N2N=C(CC2C3=CC=C(F)C=C3F)C(F)(F)F |
| Relative Density. | 1.57 g/cm3 (Predicted) |
| Color | White |
| Appearance | Solid |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (197.37 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.